TY - JOUR
T1 - Biofortified yellow cassava and Vitamin A status of Kenyan children
T2 - A randomized controlled trial
AU - Talsma, E.F.
AU - Brouwer, I.D.
AU - Verhoef, Hans
AU - Mbera, G.N.K.
AU - Mwangi, A.M.
AU - Demir, A.Y.
AU - Maziya-Dixon, B.
AU - Boy, Erick
AU - Zimmermann, M.B.
AU - Melse-Boonstra, Alida
PY - 2016
Y1 - 2016
N2 - Background: Whereas conventional white cassava roots are devoid of provitamin A, biofortified yellow varieties are naturally rich in b-carotene, the primary provitamin A carotenoid. Objective: We assessed the effect of consuming yellow cassava on serum retinol concentration in Kenyan schoolchildren with marginal vitamin A status. Design: We randomly allocated 342 children aged 5-13 y to receive daily, 6 d/wk, for 18.5 wk 1) white cassava and placebo supplement (control group), 2) provitamin A-rich cassava (mean content: 1460 μg β-carotene/d) and placebo supplement (yellow cassava group), and 3) white cassava and β-carotene supplement (1053 mg/d; β-carotene supplement group). The primary outcome was serum retinol concentration; prespecified secondary outcomes were hemoglobin concentration and serum concentrations of β-carotene, retinol-binding protein, and prealbumin. Groups were compared by using ANCOVA, adjusting for inflammation, baseline serum concentrations of retinol and β-carotene, and stratified design. Results: The baseline prevalence of serum retinol concentration
AB - Background: Whereas conventional white cassava roots are devoid of provitamin A, biofortified yellow varieties are naturally rich in b-carotene, the primary provitamin A carotenoid. Objective: We assessed the effect of consuming yellow cassava on serum retinol concentration in Kenyan schoolchildren with marginal vitamin A status. Design: We randomly allocated 342 children aged 5-13 y to receive daily, 6 d/wk, for 18.5 wk 1) white cassava and placebo supplement (control group), 2) provitamin A-rich cassava (mean content: 1460 μg β-carotene/d) and placebo supplement (yellow cassava group), and 3) white cassava and β-carotene supplement (1053 mg/d; β-carotene supplement group). The primary outcome was serum retinol concentration; prespecified secondary outcomes were hemoglobin concentration and serum concentrations of β-carotene, retinol-binding protein, and prealbumin. Groups were compared by using ANCOVA, adjusting for inflammation, baseline serum concentrations of retinol and β-carotene, and stratified design. Results: The baseline prevalence of serum retinol concentration
KW - Biofortification
KW - Efficacy
KW - Food-based approach
KW - Nutrition-sensitive intervention
KW - Vitamin A
U2 - 10.3945/ajcn.114.100164
DO - 10.3945/ajcn.114.100164
M3 - Article
AN - SCOPUS:84953911629
SN - 0002-9165
VL - 103
SP - 258
EP - 267
JO - American Journal of Clinical Nutrition
JF - American Journal of Clinical Nutrition
IS - 1
ER -